MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancerAoïfe Lowery, Michael J. Kerin|Breast Cancer Research|2009Cited by 447
Systemic <i>miRNA-195</i> Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage DiseaseHelen Heneghan, Michael J. Kerin|The Oncologist|2010Cited by 312
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGSMelissa C. Southey, Kyriaki Michailidou, Elizabeth J. van Rensburg et al.|Journal of Medical Genetics|2016Cited by 217
Prognostic significance of oestrogen receptor β in breast cancerValerie Speirs, Michael J. Kerin|British journal of surgery|2000Cited by 71